Two-Pore Domain Potassium Channels as Drug Targets: Anesthesia and Beyond.

Annual Review of Pharmacology and Toxicology
Alistair MathiePaul D Wright

Abstract

Two-pore domain potassium (K2P) channels stabilize the resting membrane potential of both excitable and nonexcitable cells and, as such, are important regulators of cell activity. There are many conditions where pharmacological regulation of K2P channel activity would be of therapeutic benefit, including, but not limited to, atrial fibrillation, respiratory depression, pulmonary hypertension, neuropathic pain, migraine, depression, and some forms of cancer. Up until now, few if any selective pharmacological regulators of K2P channels have been available. However, recent publications of solved structures with small-molecule activators and inhibitors bound to TREK-1, TREK-2, and TASK-1 K2P channels have given insight into the pharmacophore requirements for compound binding to these sites. Together with the increasing availability of a number of novel, active, small-molecule compounds from K2P channel screening programs, these advances have opened up the possibility of rational activator and inhibitor design to selectively target K2P channels.

References

May 13, 1999·Nature Neuroscience·A J PatelM Lazdunski
Apr 1, 2000·The Journal of Biological Chemistry·F MaingretE Honoré
Nov 4, 2000·The Journal of Biological Chemistry·S RajanC Derst
Mar 21, 2001·Nature Reviews. Neuroscience·S A GoldsteinN Zilberberg
May 18, 2001·Trends in Neurosciences·A J Patel, E Honoré
Feb 28, 2003·Molecular Pharmacology·Gábor Czirják, Péter Enyedi
Jun 5, 2003·Proceedings of the National Academy of Sciences of the United States of America·Lin PeiTimothy Hoey
Jul 30, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Allison P BergDouglas A Bayliss
Dec 21, 2004·The Journal of Pharmacology and Experimental Therapeutics·Svetlana TertyshnikovaNicholas J Lodge
Feb 3, 2005·British Journal of Pharmacology·Louise E KennardAlistair Mathie
Aug 3, 2005·Pflügers Archiv : European journal of physiology·Masayuki TakahiraKazuhisa Sugiyama
May 6, 2006·The EMBO Journal·Abdelkrim AllouiMichel Lazdunski
Aug 15, 2006·Nature Neuroscience·Catherine HeurteauxMichel Lazdunski
Mar 22, 2007·Nature Reviews. Neuroscience·Eric Honoré
Sep 19, 2007·The Journal of Pharmacology and Experimental Therapeutics·Anni-Maija LindenEsa R Korpi
Apr 18, 2008·The Journal of Biological Chemistry·Catherine E ClarkeAlistair Mathie
Mar 13, 2009·The EMBO Journal·Jacques NoëlMichel Lazdunski
Aug 12, 2009·Proceedings of the National Academy of Sciences of the United States of America·Guillaume SandozFlorian Lesage
Mar 31, 2010·The Journal of General Physiology·Patricia Ortega-SáenzJosé López-Barneo
Apr 16, 2010·Physiological Reviews·Péter Enyedi, Gábor Czirják
Jun 4, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Roman M LazarenkoDouglas A Bayliss
Jul 8, 2010·The Journal of Biological Chemistry·Emma L VealeStefan Trapp
Mar 3, 2011·The Journal of Biological Chemistry·Anne K StreitNiels Decher
Jul 19, 2011·The EMBO Journal·Sviatoslav N BagriantsevDaniel L Minor
Aug 9, 2011·The EMBO Journal·Paula L PiechottaThomas Baukrowitz
Aug 31, 2011·Hypertension·Eric E LloydRobert M Bryan
Jan 26, 2012·Molecular and Cellular Neurosciences·Barnaby MarshSally N Lawson
Jan 28, 2012·Science·Alexandria N Miller, Stephen B Long

❮ Previous
Next ❯

Citations

Aug 29, 2020·Cells·Margarida LorigoElisa Cairrao
Apr 23, 2021·Journal of Molecular Biology·Andrew M NataleDaniel L Minor
May 28, 2021·Biochemistry and Biophysics Reports·Yvonne WalshAlistair Mathie

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Related Papers

Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
Li-Ming LeeTobias Ruck
Handbook of Experimental Pharmacology
Jordie M KamueneLeigh D Plant
© 2021 Meta ULC. All rights reserved